1-14 of 14 Books

Selective COX-2 inhibitors
By John R. Vane,Jack H. Botting

New targets in inflammation
By Jack H. Botting,John R. Vane,N. Bazan,Jack H Botting

COX-2 blockade in cancer prevention and therapy
By Randall E. Harris

Clinical Significance And Potential Of Selective Cox-2 Inhibitors
By John R. Vane

Eicosanoids, aspirin, and asthma
By Ryszard Gryglewski,John R. Vane
Prostaglandin synthetase inhibitors
Prostaglandin synthetase inhibitors
By Symposium "Les Prostaglandines en clinique humaine" (1979 Paris, France)

Comparative pathophysiology and toxicology of cyclooxygenases
By Zaher A. Radi
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis
The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis
By Andreas Maetzel
Studies on meloxicam (Mobic) a cyclooxygenase inhibitor with selectivity towards COX-2
Studies on meloxicam (Mobic) a cyclooxygenase inhibitor with selectivity towards COX-2
By John R. Vane